Pharmavite, known for its Nature Made vitamins, has expanded its presence in the women’s health market with the acquisition of Bonafide Health for $425 million. This move adds Bonafide Health, alongside Uqora and Equelle, to Pharmavite’s portfolio, reinforcing its status as a frontrunner in providing innovative and science-backed health solutions for women.
Founded in 2017, Bonafide Health has been working on creating a new standard in menopause management, offering a range of over-the-counter products that blend scientific rigor with natural inspiration. Their product line addresses a variety of age-related women’s health needs like hot flashes, vaginal dryness, and sexual satisfaction, all backed by clinical evidence and healthcare professional endorsements.
Jeff Boutelle, CEO of Pharmavite, commented: “We’re thrilled to welcome Bonafide Health to Pharmavite. This acquisition positions us as the nation’s leading women’s health nutraceutical company, signaling a new era of innovation and science-based solutions in this underserved space. Bonafide’s unwavering commitment to research, development, and robust scientific evidence mirrors Pharmavite’s rigorous standards, while its deep relationship with healthcare professionals aligns with our goal of ensuring nutrition education is at the forefront of the industry.”
Michael Satow Co-Founder and CEO of Bonafide Health shared: “Our steadfast commitment to science and innovation has allowed us to build something special at Bonafide Health and we’ve been looking for the right partner to grow the business and reach more women that need support. Pharmavite is that partner. Pharmavite deeply understands the importance of the model we’ve built, from the rigorous scientific data that underpins our products, to the power of the work we do with the doctors and other health care providers who are having conversations with women across the country looking for better solutions.”
Pharmavite will continue to operate from its Harrison, NY headquarters in the U.S.. With this acquisition, there are no immediate workforce changes.
